CIK: 0001503556
Total reported value
$60.1M
Reporting period: 2023-09-30 · Number of holdings: 3
MV Management XI, L.L.C. disclosed 3 holdings in its latest 13F filing for the period ending 2023-09-30, with total reported value of $60.1M and a quarterly turnover rate of 0.0%.
Browse other institutions with under $100M AUMBrowse other institutions starting with "M"
MV Management XI, L.L.C.'s disclosed holdings carry a Herfindahl concentration index of 0.819 — mathematically equivalent to about 1 equally-sized positions, well below its 3 actual disclosed holdings. That gap points to a strategy built around a small core of high-conviction bets rather than broad diversification.
Position sizes vary widely across the portfolio (a coefficient of variation of 1.48), with a handful of outsized bets alongside many smaller positions.
No strong tilt toward either adding to existing winners or initiating outsized new positions was observed in the latest reported quarter.
Sector classification currently covers about 10% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
No holding changes this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | TLRY | Tilray Brands, Inc. | Stock-Other | 89.96% | — | — | |
| 2 | RXRX | Recursion Pharmaceuticals-a | Stock-Healthcare | 10.04% | — | -60.00% | |
| 3 | ANGI1EUR | Angi INC | Stock-Other | 0.01% | — | — |
Performance for Q3 2026
-30.3%
Performance Last 4 Quarters
-28%
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2023-09-30 | 3 | $60.1M | 0 | |
| 2023-06-30 | 3 | $57.2M | 0 | |
| 2023-03-31 | 3 | $65.3M | 0 | |
| 2022-12-31 | 3 | $57.5M | 0 | |
| 2022-09-30 | 4 | $138.0M | 0 | |
| 2022-06-30 | 4 | $110.0M | 0 | |
| 2022-03-31 | 4 | $144.0M | 0 | |
| 2021-12-31 | 4 | $231.5M | 0 |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2023-09-30 | 2023-11-14 | 13F-HR | View on EDGAR |
| 2023-06-30 | 2023-07-24 | 13F-HR | View on EDGAR |
| 2023-03-31 | 2023-05-02 | 13F-HR | View on EDGAR |
| 2022-12-31 | 2023-01-31 | 13F-HR | View on EDGAR |
| 2022-09-30 | 2022-11-14 | 13F-HR | View on EDGAR |
| 2022-06-30 | 2022-07-28 | 13F-HR | View on EDGAR |
| 2022-03-31 | 2022-05-16 | 13F-HR | View on EDGAR |
| 2021-12-31 | 2022-02-15 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0002023709
Total reported value
$60.1M
76 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001218269
Total reported value
$60.1M
17 stks
2013-09-30
Stale — no recent filing
AUM within 0.0% of this institution
CIK 0001424071
Total reported value
$60.1M
1 stks
2023-09-30
Stale — no recent filing
AUM within 0.0% of this institution
Institutions with overlapping top holdings
CIK 0001615420
Total reported value
$55.5M
3 stks
2022-09-30
Stale — no recent filing
1 of the top 5 holdings overlap, including Tilray Brands, Inc.
CIK 0001644978
Total reported value
$209.0M
4 stks
2022-09-30
Stale — no recent filing
1 of the top 5 holdings overlap, including Tilray Brands, Inc.
CIK 0001664974
Total reported value
$55.9M
4 stks
2026-03-31
1 of the top 5 holdings overlap, including Recursion Pharmaceuticals-a